110 likes | 350 Views
Immunosuppression (IS) 1954 – 2005. Malononitrilamides (FK778). Everolimus (RAD). Sirolimus (SRL). Mycophenolate mofetil (MMF). Leflunomide. Tacrolimus (Tac). FTY720. Cyclosporine A (CsA). Azathioprine (Aza). Steroids. OKT 3. CTLA4Ig. Campath1H. monoclonal antibodies.
E N D
Immunosuppression (IS) 1954 – 2005 Malononitrilamides (FK778) Everolimus (RAD) Sirolimus (SRL) Mycophenolate mofetil (MMF) Leflunomide Tacrolimus (Tac) FTY720 Cyclosporine A (CsA) Azathioprine (Aza) Steroids OKT 3 CTLA4Ig Campath1H monoclonal antibodies polyclonal antibodies TBI - radiation 1950 1960 1970 1980 1990 2000 2010
Targets of different IS drugs Co-stimulatorySignal AntigenicSignal APC IL-2 receptor TCR DaclizumabBasiliximab m-TOR (SRL/ EVL) Ca2+ T-cell De novopurine synthesis CNIs IL-2 AZA P ActivatedCalcineurin MMF S G1 NFAT CellCycle Steroid NFAT M G2 + IL-2 gene promotor
MMF - Mechanism of action • MMF selectively and reversibly inhibits IMPDH (B- and T-lymphocytes); it’s not incorporated into DNA • AZA blocks proliferation of all rapidly dividing cells in a non-selective way and is incorporated into DNA (mutagenic), explaining the adverse effects and limiting the doses needed for accurate immunosuppression
MMF - Mechanism of action Inhibition of de novo purine synthesis dGTP DNA De novo pathway RNA dGDP IMPDH GTP GMP IMP PRPP Glycoprotein synthesis HGPRTase MPA MMF Salvage pathway Guanine
MMF - Mechanism of action Dependence on de novo synthesis Dependence on major salvage pathway Erythroid precursors intestinal epithelial cells Promonocytes Lymphocytes Neurons